These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 34842834)

  • 1. High Prevalence of SARS-CoV-2 in an Indigenous Community of the Colombian Amazon Region.
    Serrano-Coll H; Miller H; Rodríguez-Van Der Hamen C; Gastelbondo B; Novoa W; Oviedo M; Rivero R; Garay E; Mattar S
    Trop Med Infect Dis; 2021 Oct; 6(4):. PubMed ID: 34842834
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes.
    Garay E; Serrano-Coll H; Rivero R; Gastelbondo B; Faccini-Martínez Á; Berrocal J; Pérez A; Badillo M; Martínez-Bravo C; Botero Y; Arrieta G; Calderón A; Galeano K; López Y; Miranda J; Guzmán C; Contreras V; Arosemena A; Contreras H; Brango-Tarra E; Oviedo M; Mattar S
    Trans R Soc Trop Med Hyg; 2022 Feb; 116(2):139-147. PubMed ID: 34185868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of the CoronaVac® vaccine in a region of the Colombian Amazon, was herd immunity achieved?
    Serrano-Coll H; Miller H; Guzmán C; Rivero R; Gastelbondo B; Miranda J; Galeano K; Montaña-Restrepo J; Mattar S
    Trop Dis Travel Med Vaccines; 2022 Jan; 8(1):2. PubMed ID: 35031076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.
    Mattar S; Martinez-Bravo C; Rivero R; Contreras H; Faccini-Martínez ÁA; Guzman-Teran C; Galeano K; Alvis-Guzman N; Contreras V; Arrieta G; Gonzalez-Tous M; Miranda J; Ospina M; Camargo-Assis F; Mercado-Reyes M; Garay E; Garcia-Perez A; Lopez Y; Tique V
    Ann Clin Microbiol Antimicrob; 2020 Dec; 19(1):58. PubMed ID: 33287846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migration in times of pandemic: SARS-CoV-2 infection among the Warao indigenous refugees in Belém, Pará, Amazonia, Brazil.
    da Silva HP; Abreu IN; Lima CNC; de Lima ACR; do Nascimento Barbosa A; de Oliveira LR; Fujishima MA; Lima SS; de Lima VN; Castelo-Branco S; Vallinoto ACR
    BMC Public Health; 2021 Sep; 21(1):1659. PubMed ID: 34511064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.
    Hallal PC; Hartwig FP; Horta BL; Silveira MF; Struchiner CJ; Vidaletti LP; Neumann NA; Pellanda LC; Dellagostin OA; Burattini MN; Victora GD; Menezes AMB; Barros FC; Barros AJD; Victora CG
    Lancet Glob Health; 2020 Nov; 8(11):e1390-e1398. PubMed ID: 32979314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 quantitative real time PCR and viral loads analysis among asymptomatic and symptomatic patients: an observational study on an outbreak in two nursing facilities in Campania Region (Southern Italy).
    Cardillo L; de Martinis C; Viscardi M; Esposito C; Sannino E; Lucibelli G; Limone A; Pellino S; Anastasio R; Pellicanò R; Baldi L; Galiero G; Fusco G
    Infect Agent Cancer; 2021 Jun; 16(1):45. PubMed ID: 34158108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
    Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19.
    Almadhi MA; Abdulrahman A; Sharaf SA; AlSaad D; Stevenson NJ; Atkin SL; AlQahtani MM
    Int J Infect Dis; 2021 Apr; 105():656-661. PubMed ID: 33647516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel.
    Jacob JT; Baker JM; Fridkin SK; Lopman BA; Steinberg JP; Christenson RH; King B; Leekha S; O'Hara LM; Rock P; Schrank GM; Hayden MK; Hota B; Lin MY; Stein BD; Caturegli P; Milstone AM; Rock C; Voskertchian A; Reddy SC; Harris AD
    JAMA Netw Open; 2021 Mar; 4(3):e211283. PubMed ID: 33688967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the introduction and transmission of SARS-CoV-2 in the Colombian Amazon Basin.
    Ballesteros N; Muñoz M; Patiño LH; Hernández C; González-Casabianca F; Carroll I; Santos-Vega M; Cascante J; Angel A; Feged-Rivadeneira A; Palma-Cuero M; Flórez C; Gomez S; van de Guchte A; Khan Z; Dutta J; Obla A; Alshammary HA; Gonzalez-Reiche AS; Hernandez MM; Sordillo EM; Simon V; van Bakel H; Paniz-Mondolfi AE; Ramírez JD
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009327. PubMed ID: 33857136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.
    Angulo FJ; Finelli L; Swerdlow DL
    JAMA Netw Open; 2021 Jan; 4(1):e2033706. PubMed ID: 33399860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.
    Varona JF; Madurga R; Peñalver F; Abarca E; Almirall C; Cruz M; Ramos E; Castellano Vázquez JM
    Int J Epidemiol; 2021 May; 50(2):400-409. PubMed ID: 33434269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence and lethality by SARS-CoV-2 in indigenous populations of Latin America and the Caribbean: a systematic review.
    Hernández-Vásquez A; Chavez-Ecos F; Barrenechea-Pulache A; Comandé D; Bendezu-Quispe G
    PeerJ; 2021; 9():e12552. PubMed ID: 35003919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Clinical and Epidemiological Characteristics of Asymptomatic and Symptomatic SARS-CoV-2 Infection in Children.
    Cai J; Wang X; Zhao J; Ge Y; Xu J; Tian H; Chang H; Xia A; Wang J; Zhang J; Wei Z; Li J; Wang C; Wang J; Zhu Q; Zhai X; Zeng M
    Virol Sin; 2020 Dec; 35(6):803-810. PubMed ID: 33146873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-sectional investigation of SARS-CoV-2 seroprevalence and associated risk factors in children and adolescents in the United States.
    Levorson RE; Christian E; Hunter B; Sayal J; Sun J; Bruce SA; Garofalo S; Southerland M; Ho S; Levy S; Defillipi C; Peake L; Place FC; Hourigan SK
    PLoS One; 2021; 16(11):e0259823. PubMed ID: 34748615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study.
    Stefanelli P; Bella A; Fedele G; Pancheri S; Leone P; Vacca P; Neri A; Carannante A; Fazio C; Benedetti E; Fiore S; Fabiani C; Simmaco M; Santino I; Zuccali MG; Bizzarri G; Magnoni R; Benetollo PP; Merler S; Brusaferro S; Rezza G; Ferro A
    Clin Microbiol Infect; 2021 Apr; 27(4):633.e1-633.e7. PubMed ID: 33253941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
    Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
    Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
    Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
    Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.